Accelerated timelines are critical when responding to an outbreak and efficient vaccine manufacturing is required to enable a quicker transition from research to the clinic, saving lives.mRNAs allow biotechnology companies to develop vaccines in response to pandemics, such as COVID-19, in a matter of weeks.
